Daiwa Securities Group Inc. - ORIC PHARMACEUTICALS INC ownership

ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 83 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of ORIC PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$0
-100.0%
1350.0%0.00%
Q2 2022$1,0000.0%1350.0%0.00%
Q1 2022$1,000
-50.0%
1350.0%0.00%
Q4 2021$2,000
-33.3%
1350.0%0.00%
Q3 2021$3,000
+200.0%
135
+95.7%
0.00%
Q2 2021$1,000
-50.0%
690.0%0.00%
Q1 2021$2,0000.0%690.0%0.00%
Q4 2020$2,000690.00%
Other shareholders
ORIC PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,007,576$25,199,00012.12%
Svennilson Peter 4,768,181$119,252,0009.73%
EcoR1 Capital, LLC 2,642,218$66,082,0004.71%
Orbimed Advisors 2,921,967$73,078,0000.92%
EMERALD MUTUAL FUND ADVISERS TRUST 312,483$7,815,0000.35%
EMERALD ADVISERS, LLC 324,582$8,118,0000.33%
Casdin Capital, LLC 251,515$6,290,0000.28%
ArrowMark Colorado Holdings LLC 995,382$24,895,0000.24%
Artal Group S.A. 142,500$3,564,0000.09%
Alyeska Investment Group, L.P. 161,585$4,041,0000.06%
View complete list of ORIC PHARMACEUTICALS INC shareholders